Companies / Colombia
Pfizer Told To Stop Marketing Viagra
November 2006 | Legal NewsA Colombian judge has ordered US firm Pfizer to withdraw its erectile dysfunction drug Viagra (sildenafil) from the market because it violates the registration documents of local firm Lafrancol's equivalent product Eroxim (sildenafil). BMI believes that this case is another example of the difficulties facing foreign companies with regard to intellectual property protection in the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
